Table: Torii Pharmaceutical - 9-MTH parent results
Oct 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2022 Sep 30, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 35.32 33.44 49.20
(+10.8 pct)
Operating 4.07 3.15 6.00
(+28.9 pct) (-11.3 pct) (+28.9 pct)
Recurring 3.92 3.26 6.00
(+20.3 pct) (-13.2 pct) (+23.8 pct)
Net 2.86 2.24 4.30
(+27.6 pct) (-10.8 pct) (+27.4 pct)
EPS 101.66 yen 79.68 yen 153.05 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)